ArticleBioMed research international2016

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.

Kyoko Nitta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.